Issue of Equity

RNS Number : 3707G
FD Technologies PLC
15 November 2022
 

15 November 2022

FD Technologies plc

("FD Technologies" or the "Company")

Issue of Equity

 

 

FD Technologies (AIM: FDP.L, Euronext Growth: FDP.I) announces that on 14 November 2022 the Company allotted 14,000 new ordinary shares of £0.005 each in the Company ("the Ordinary Shares") pursuant to the exercise of share options by certain employees.

 

Application has been made for the new Ordinary Shares to be admitted to trading on AIM and Euronext Growth and it is expected that admission will take place on 18 November 2022. The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following this allotment, the total issued share capital of the Company will increase to 28,031,354 ordinary shares.

 

Enquiries

For further information please contact:

 

FD Technologies plc

Seamus Keating, Chief Executive Officer

Ryan Preston, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44 (0) 28 3025 2242

www.fdtechnologies.com



Investec Bank plc (Nominated Adviser and Broker)

Carlton Nelson

Virginia Bull

+44 (0) 20 7597 5970



Goodbody (Euronext Growth Adviser and Broker)

David Kearney

Don Harrington

Finbarr Griffin

+353 1 667 0420



J.P. Morgan Cazenove (Broker)

James A. Kelly

Mose Adigun

 

+44 (0) 20 7742 4000

 

About FD Technologies

FD Technologies is a group of data-driven businesses that unlock the value of insight, hindsight and foresight to drive organisations forward. The Group comprises KX, the leading technology for real-time continuous intelligence; First Derivative, which provides technology-led services in capital markets; and MRP, the only enterprise-class, predictive Accounts Based Marketing solution. FD Technologies operates from 14 offices across Europe, North America and Asia Pacific, and employs more than 3,100 people worldwide.

 

For further information, please visit www.fdtechnologies.com and www.kx.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFLFVALELSLIF
UK 100

Latest directors dealings